Roivant Sciences Ltd (ROIV)

Debt-to-capital ratio

		Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020
Long-term debt	US$ in thousands	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Total stockholders’ equity	US$ in thousands	4,687,600	5,189,470	5,580,040	5,435,310	5,968,580	6,089,760	948,534	910,730	1,157,770	955,520	1,160,600	1,384,110	2,038,940	2,247,260	2,038,020	1,723,120	1,797,790	—
Debt-to-capital ratio		0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—

March 31, 2025 calculation

Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $—K ÷ ($—K + $4,687,600K)
= 0.00

Based on the provided data, Roivant Sciences Ltd has maintained a consistent debt-to-capital ratio of 0.00% from December 31, 2020, to March 31, 2025. A debt-to-capital ratio of 0.00% indicates that the company has not utilized any debt to finance its operations and investments during this period. This could suggest that Roivant Sciences Ltd relies primarily on equity financing or has successfully managed to operate without taking on significant levels of debt.

A debt-to-capital ratio of 0.00% may indicate a conservative financial strategy, as the company is not heavily reliant on debt to fund its operations. It could also imply a lower financial risk compared to companies with higher debt levels, as the absence of debt obligations reduces interest expenses and potential financial burden.

Overall, the consistent 0.00% debt-to-capital ratio for Roivant Sciences Ltd suggests a stable and potentially financially sound position with minimal leverage and a balanced capital structure. Investors and stakeholders may view this as a positive indicator of financial prudence and risk management by the company.